NASDAQ Gives Dynatronics a Third Three-Month Extension for Minimum Bid Price Compliance
Posted on: Tuesday, 31 March 2009, 09:40 CDT
"We are pleased that NASDAQ has again extended the timeframe for compliance," stated
Dynatronics recently reported a profit for the quarter ended
"In the quarter ending
Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at www.dynatronics.com.
This press release contains forward-looking statements. Those statements include references to the company's expectations for future events. Such statements are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements in this press release include the statements concerning anticipated improvements for the quarter ending
SOURCE Dynatronics Corporation
Source: PR Newswire
Related Articles
- Magal S3 to Release Third Quarter 2009 Results on November 30, 2009
- American Pacific Reports Fiscal 2009 Third Quarter Results - Reaffirms Fiscal Earnings 2009 Guidance
- American Pacific to Release Financial Results and Hold Fiscal 2009 Third Quarter Investor Teleconference
- Endo Pharmaceuticals to Announce Second Quarter 2009 Financial Results on July 30, 2009
- China Finance Online to Announce 1Q 2009 Financial Results on May 26, 2009
- Endo Pharmaceuticals to Announce First Quarter 2009 Financial Results on April 29, 2009
- SmartHeat Inc. to Report Fiscal Year 2008 Financial Results on March 18, 2009 Before Market Opens
- Arabian American Development Company to Announce 2008 Fourth Quarter and Year End Results on March 12, 2009
- American Pacific to Release Financial Results and Hold Fiscal 2009 First Quarter Investor Teleconference
- Endo Pharmaceuticals to Announce Fourth Quarter and 2008 Full-Year Financial Results on February 27, 2009
User Comments (0)

RSS Feeds